Governor Dannel P. Malloy, joined by state Department of Administrative Services (DAS) Commissioner Donald DeFronzo, state Department of Economic and Community Development (DECD) Commissioner Catherine Smith, Head of Pfizer Pharmatherapeutics R&D Rod MacKenzie, PhD, CURE president and CEO Susan Froshauer, PhD, representatives from Connecticut’s bioscience research organizations, and other state and local officials, today announced that an agreement has been reached to put two vacant buildings on Pfizer’s Groton campus back into productive reuse as a bioscience innovation center and as a new DAS state data center … view Governor’s press release

The new bioscience facility, CURE Innovation Commons, will comprise approximately 24,000 square feet, and house up to seven laboratories, numerous offices, conference rooms and a large meeting space. The Commons promises to be a valuable resource for Southeastern Connecticut technology companies and scientific talent. Learn more about CURE Innovation Commons here.